Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018007507) REINFORCED PHARMACEUTICAL DOSAGE FORM
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/007507 International Application No.: PCT/EP2017/066907
Publication Date: 11.01.2018 International Filing Date: 06.07.2017
Chapter 2 Demand Filed: 26.04.2018
IPC:
A61K 9/20 (2006.01) ,A61K 31/135 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
13
Amines, e.g. amantadine
135
having aromatic rings, e.g. methadone
Applicants:
GRÜNENTHAL GMBH [DE/DE]; Zieglerstraße 6 52078 Aachen, DE
Inventors:
HAUPTS, Marcel; DE
WENING, Klaus; DE
STOMBERG, Carmen; DE
EBNER, Siegfried; DE
Agent:
KUTZENBERGER WOLFF & PARTNER; Theodor-Heuss-Ring 23 50668 Köln, DE
Priority Data:
16178238.806.07.2016EP
Title (EN) REINFORCED PHARMACEUTICAL DOSAGE FORM
(FR) FORME POSOLOGIQUE PHARMACEUTIQUE RENFORCÉE
Abstract:
(EN) The invention relates to a reinforced pharmaceutical dosage form comprising a pharmacologically active ingredient and fibers. The reinforced pharmaceutical dosage form is tamper-resistant and thus useful for the avoidance of drug abuse or misuse. The invention also relates to the preparation of such dosage forms and their use in therapy.
(FR) L'invention concerne une forme posologique pharmaceutique renforcée comprenant un ingrédient pharmacologiquement actif et des fibres. La forme posologique pharmaceutique renforcée est inviolable et est donc utile pour éviter l'abus de drogues ou un mauvais usage. L'invention concerne également la préparation de telles formes posologiques et leur utilisation en thérapie.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)